Why is Genomma Lab Internacional SAB de CV ?
1
The company is Net-Debt Free
- Poor long term growth as Operating profit has grown by an annual rate 4.11% of over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 14.48% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 26
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.15 times
- OPERATING PROFIT(Q) Lowest at MXN 963.41 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 21.91 %
3
With ROE of 13.69%, it has a very expensive valuation with a 1.34 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -34.25%, its profits have fallen by -29.2%
4
Below par performance in long term as well as near term
- Along with generating -34.25% returns in the last 1 year, the stock has also underperformed Mexico IPC in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Genomma Lab Internacional SAB de CV for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Genomma Lab Internacional SAB de CV
-100.0%
43.02
33.96%
Mexico IPC
14.41%
0.77
19.31%
Quality key factors
Factor
Value
Sales Growth (5y)
4.24%
EBIT Growth (5y)
4.11%
EBIT to Interest (avg)
3.35
Debt to EBITDA (avg)
1.30
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
1.00
Tax Ratio
32.54%
Dividend Payout Ratio
48.39%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
22.29%
ROE (avg)
14.48%
Valuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.34
EV to EBIT
5.81
EV to EBITDA
5.15
EV to Capital Employed
1.23
EV to Sales
1.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.22%
ROE (Latest)
13.69%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Movement
2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -1.7% (YoY
CASH AND EQV(HY)
Highest at MXN 5,043.72 MM
-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.15 times
OPERATING PROFIT(Q)
Lowest at MXN 963.41 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 21.91 %
PRE-TAX PROFIT(Q)
Lowest at MXN 534.73 MM
Here's what is working for Genomma Lab Internacional SAB de CV
Cash and Eqv
Highest at MXN 5,043.72 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -1.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Genomma Lab Internacional SAB de CV
Operating Profit
Lowest at MXN 963.41 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (MXN MM)
Operating Profit Margin
Lowest at 21.91 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at MXN 534.73 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (MXN MM)
Debtors Turnover Ratio
Lowest at 2.15 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






